This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Ketorolac 30 mg/mL vials. The contract has a ceiling value of $2,125.73 and a completion date of September 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical to supply a comprehensive range of medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ketorolac 30 mg/ml vial. The contract has a firm fixed price, is not set aside, and has a ceiling value of $4,102.92. The ultimate completion date is October 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Ketorolac 30 mg/ml injectable medication. The contract is a firm-fixed price delivery order with a ceiling value of $1,874.80 and an ultimate completion date of August 21, 2024. This order is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ketorolac 30 mg/mL vials. The contract has a firm fixed price of $1,454.70 and a completion date of February 7, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ketorolac 30 mg/ml vial. The contract has a ceiling value of $3,879.20 and a period of performance through February 20, 2025. It is a firm-fixed-price contract and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of Ketorolac 30 mg/ml vials, a prescription medication. The contract has a ceiling value of $1,326.96 and is a firm-fixed-price delivery order with a completion date of May 28, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a substantial Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,407.92 firm fixed-price contract is for the supply of Ketorolac 30 mg/mL vial, a pharmaceutical product. The order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to procure a comprehensive range of medical commodities from Amerisourcebergen to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ketorolac 30 mg/mL vials. The contract has a firm fixed price, with a ceiling value of $1,874.80, and an ultimate completion date of September 3, 2024. The contract is not set-aside. Amerisourcebergen, through its extensive supply chain network, will provide this critical pharmaceutical product to support various military...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Ketorolac 30mg/mL, a prescription medication, in quantities of 25 vials. The potential value of this delivery order is $11,248.80, with a completion date of February 14, 2024. This award is not...
This is a $1,939.60 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 30 mg/mL ketorolac vials, a pain management pharmaceutical. The delivery order has a firm fixed price, with a completion date of June 27, 2025. This contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...